Cosmo Pharmaceuticals
C43.F
$75.60
Share price
-0.70%
Change (1 day)
23.98%
Change (1 year)
Categories
Earnings for Cosmo Pharmaceuticals (C43.F)
Earnings in 2022: $26.2 M
According to Cosmo Pharmaceuticals's latest financial reports the company's current earnings (TTM) are $26.2 M. In 2022 the company made an earning of $26.2 M a decrease over its 2021 earnings that were of $27.18 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Cosmo Pharmaceuticals from 2004 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 | $26.2 M | -3.58% |
| 2021 | $27.18 M | -418.87% |
| 2020 | -$8.53 M | -64.28% |
| 2019 | -$23.87 M | 19.49% |
| 2018 | -$19.98 M | -48.7% |
| 2017 | -$38.94 M | -234.54% |
| 2016 | $28.93 M | -89.59% |
| 2015 | $0.27 B | 110.02% |
| 2014 | $0.13 B | 33.75% |
| 2013 | $98.97 M | 177.69% |
| 2012 | $35.64 M | 202.46% |
| 2011 | $11.78 M | 98.69% |
| 2010 | $5.93 M | -22.14% |
| 2009 | $7.61 M | -53.08% |
| 2008 | $16.23 M | 7167.3% |
| 2007 | $0.22 M | -66.47% |
| 2006 | $0.66 M | -57% |
| 2005 | $1.54 M | -193.61% |
| 2004 | -$1.66 M |